Rift Between Insurance Industry, Pharma On Full Display As Sides Debate Democrats’ Plan To Lower Drug Prices

When it comes to high health care costs, the big players in the industry often point fingers at each other as the culprits, which can make coming to a consensus on lowering costs challenging. The debate was on display at the final panel of the Milken Institute’s Future of Health Summit Wednesday, with insurers and pharma representatives sparring over the Democrats' plan. Meanwhile, lawmakers introduce a bipartisan measure to tackle generic drug costs for seniors.

from Kaiser Health News https://ift.tt/34iF1Oo